Comparative efficacy between atorvastatin and rosuvastatin in the prevention of cardiovascular disease recurrence
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-511X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Comparative efficacy between atorvastatin and rosuvastatin in the prevention of cardiovascular disease recurrence ; volume:18 ; number:1 ; day:11 ; month:12 ; year:2019 ; pages:1-6 ; date:12.2019
Lipids in health and disease ; 18, Heft 1 (11.12.2019), 1-6, 12.2019
- Urheber
-
Perez-Calahorra, Sofía
Laclaustra, Martin
Marco-Benedi, Victoria
Pinto, Xavier
Sanchez-Hernandez, Rosa M.
Plana, Núria
Ortega, Emilio
Fuentes, Francisco
Civeira, Fernando
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12944-019-1153-x
- URN
-
urn:nbn:de:101:1-2020040510051105985963
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Perez-Calahorra, Sofía
- Laclaustra, Martin
- Marco-Benedi, Victoria
- Pinto, Xavier
- Sanchez-Hernandez, Rosa M.
- Plana, Núria
- Ortega, Emilio
- Fuentes, Francisco
- Civeira, Fernando
- SpringerLink (Online service)
Ähnliche Objekte (12)
Antibacterial activity of statins: a comparative study of Atorvastatin, Simvastatin, and Rosuvastatin
Rosuvastatin, but not atorvastatin, enhances the antihypertensive effect of cilostazol in an acute model of hypertension
Comparison of the efficacy and safety of rosuvastatin 10 mg and atorvastatin 20 mg in high-risk patients with hypercholesterolemia – Prospective study to evaluate the Use of Low doses of the Statins Atorvastatin and Rosuvastatin (PULSAR)
An Expert Opinion on the Role of the Rosuvastatin/Amlodipine Single Pill Fixed Dose Combination in Cardiovascular Prevention
Relationship between genetic polymorphism of drug transporters and the efficacy of Rosuvastatin, atorvastatin and simvastatin in patients with hyperlipidemia
Comparison of rosuvastatin and atorvastatin for lipid lowering in patients with type 2 diabetes mellitus: results from the URANUS study
Impact of pitavastatin on new-onset diabetes mellitus compared to atorvastatin and rosuvastatin: a distributed network analysis of 10 real-world databases
Prevention of cardiovascular diseases
Comparative Study Between the Effects of High Doses of Rosuvastatin and Atorvastatin on Ventricular Remodeling in Patients with ST-Segment Elevation Myocardial Infarction
P1.07 Rosuvastatin Increases Extracellular Adenosine in Humans in Vivo: A New Perspective on Cardiovascular Protection
Cardiovascular risk prevention in children
Atorvastatin treatment and LDL cholesterol target attainment in patients at very high cardiovascular risk
Antibacterial activity of statins: a comparative study of Atorvastatin, Simvastatin, and Rosuvastatin
Rosuvastatin, but not atorvastatin, enhances the antihypertensive effect of cilostazol in an acute model of hypertension
Comparison of the efficacy and safety of rosuvastatin 10 mg and atorvastatin 20 mg in high-risk patients with hypercholesterolemia – Prospective study to evaluate the Use of Low doses of the Statins Atorvastatin and Rosuvastatin (PULSAR)
An Expert Opinion on the Role of the Rosuvastatin/Amlodipine Single Pill Fixed Dose Combination in Cardiovascular Prevention
Relationship between genetic polymorphism of drug transporters and the efficacy of Rosuvastatin, atorvastatin and simvastatin in patients with hyperlipidemia
Comparison of rosuvastatin and atorvastatin for lipid lowering in patients with type 2 diabetes mellitus: results from the URANUS study
Impact of pitavastatin on new-onset diabetes mellitus compared to atorvastatin and rosuvastatin: a distributed network analysis of 10 real-world databases
Prevention of cardiovascular diseases
Comparative Study Between the Effects of High Doses of Rosuvastatin and Atorvastatin on Ventricular Remodeling in Patients with ST-Segment Elevation Myocardial Infarction
P1.07 Rosuvastatin Increases Extracellular Adenosine in Humans in Vivo: A New Perspective on Cardiovascular Protection
Cardiovascular risk prevention in children
Atorvastatin treatment and LDL cholesterol target attainment in patients at very high cardiovascular risk
Antibacterial activity of statins: a comparative study of Atorvastatin, Simvastatin, and Rosuvastatin
Rosuvastatin, but not atorvastatin, enhances the antihypertensive effect of cilostazol in an acute model of hypertension
Comparison of the efficacy and safety of rosuvastatin 10 mg and atorvastatin 20 mg in high-risk patients with hypercholesterolemia – Prospective study to evaluate the Use of Low doses of the Statins Atorvastatin and Rosuvastatin (PULSAR)
An Expert Opinion on the Role of the Rosuvastatin/Amlodipine Single Pill Fixed Dose Combination in Cardiovascular Prevention
Relationship between genetic polymorphism of drug transporters and the efficacy of Rosuvastatin, atorvastatin and simvastatin in patients with hyperlipidemia
Comparison of rosuvastatin and atorvastatin for lipid lowering in patients with type 2 diabetes mellitus: results from the URANUS study
Impact of pitavastatin on new-onset diabetes mellitus compared to atorvastatin and rosuvastatin: a distributed network analysis of 10 real-world databases
Prevention of cardiovascular diseases
Comparative Study Between the Effects of High Doses of Rosuvastatin and Atorvastatin on Ventricular Remodeling in Patients with ST-Segment Elevation Myocardial Infarction
P1.07 Rosuvastatin Increases Extracellular Adenosine in Humans in Vivo: A New Perspective on Cardiovascular Protection
Cardiovascular risk prevention in children